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Abstract 
Peroxiredoxins are thiol-specific antioxidants that protect cells from oxidative damage and have proliferative and 
anti-apoptotic activity. We investigated the effect of serum and phorbol ester treatment on expression of Prdx1 and Prdx6 
in H2.35 cells, and the possible role of Sp1 on Prdx6 induction. Serum stimulation induced a 30% increase in Prdx1 
mRNA and a three-fold increase in Prdx6 mRNA. We showed a similar effect of phorbol ester treatment, which led to a 
30% increase in Prdx1 mRNA, and over a two-fold increase in Prdx6 expression. Analysis of the Prdx6 proximal 
promoter sequence revealed four consensus Sp1 sites. Inhibition of Sp1 with mithramycin A blocked Prdx6 induction by 
TPA and inhibited the serum-induced transcriptional activity of the Prdx6 proximal promoter. These data suggest an 
important role for Prdx6 in the cellular response to serum and TPA, and implicate Sp1 as a possible mediator of Prdx6 
regulation. 
Keywords: Peroxiredoxin, Prdx1, Prdx6, H2.35, Antioxidant, TPA, Serum 
1. Introduction 
Reactive oxygen species (ROS) are unstable free radical derivates of oxygen formed as byproducts of many biochemical 
processes in the cell. ROS serve critical functions for many types of cells (Halliwell and Gutteridge, 1999), and recently 
have been implicated as key regulators of signal transduction (Immenschuh and Baumgart-Vogt, 2005). However, when 
concentrations of ROS become too high, macromolecules can become oxidized, causing detrimental cellular effects such 
as cell death (Halliwell and Gutteridge, 1999). These consequences have pathophysiological relevance, as oxidative stress 
is linked to the development of a number of diseases including cancer and neurodegenerative disease (Cross et al., 1987; 
Sun and Chen, 1998; Gius and Spitz, 2006).  
Peroxiredoxin proteins are thiol-specific antioxidant enzymes that reduce various cellular peroxide substrates using 
cysteine-containing active sites (Hofmann et al., 2002; Rhee et al., 2005). Mammals possess six members of the 
peroxiredoxin gene family, and the encoded proteins are classified into three groupings based on the number and position 
of active site cysteines: the 2-Cys type (Prdx1-4), the atypical 2-Cys Prdx (Prdx5), and the 1-cys member (Prdx6). In 
addition to their structural differences, these proteins vary in peroxide substrate specificity, cellular localization, tissue 
expression, and additional enzymatic activities (Hofmann et al., 2002; Rhee et al., 2005). Based on their functions, 
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peroxiredoxins can protect cells from ROS-induced cell damage and apoptosis, and regulate redox sensitive cell signaling 
involved in processes such as cell proliferation, differentiation, and transformation (Hofmann et al., 2002; Immenschuh 
and Baumgart-Vogt, 2005; Rhee et al., 2005). They now have been implicated in the modulation of disease states such as 
neurodegenerative diseases and cancer (Karihtala et al., 2003; Kinnula et al., 2004; Arner and Holmgren, 2006).  
Prdx6 is the only peroxireodoxin that contains a single conserved cysteine residue, and it utilizes glutathione as a 
reductant (Kang et al., 1998; Hofmann et al., 2002; Rhee et al., 2005). Unlike other peroxiredoxins, Prdx6 reduces both 
aqueous and lipid peroxides and possesses distinct phospholipase A2 activity (Chen et al., 2000; Manevich et al., 2004; 
Manevich and Fisher, 2005). As a result of these functions, Prdx6 appears to be involved in phospholipid metabolism and 
membrane turnover (Manevich et al., 2002; Manevich and Fisher, 2005), and we and others have demonstrated that Prdx6 
protects cells from ROS-mediated membrane damage and apoptosis (Manevich et al., 2002; Pak et al., 2002; Phelan et al., 
2003; Wang et al., 2003; Wang et al., 2004; Wang et al., 2006; Wang et al., 2006). Prior studies from our lab have reported 
an abundance of Prdx6 in liver (Sparling and Phelan, 2003; Wang et al., 2003), and its transcriptional regulation by 
various oxidative stresses in H2.35 cells, a virally transformed mouse hepatocyte cell line (Sparling and Phelan, 2003; 
Simeone and Phelan, 2005; Gallagher and Phelan, 2007). A recent report demonstrated that Prdx6-knockout mice exhibit 
a significant increase in hepatocellular injury (Eismann et al., 2009), confirming an important antioxidant role for this 
protein in liver. Prdx1, the most ubiquitous peroxiredoxin, is also highly expressed in liver (Ishii et al., 1993; Ishii et al.,
1995; Ishii et al., 2000), although its regulation has largely been studied in non-liver tissues. Originally named PAG 
(proliferation associated gene) in human (Prospéri et al., 1993), Prdx1 is overexpressed during cell proliferation and is 
transcriptionally induced by serum in human mammary epithelial cells (Prospéri et al., 1993). Prdx1 is also induced by the 
tumor promoter phorbol-12-myristate-13-acetate (TPA) in liver tissue macrophages (Hess et al., 2003). Since liver tissue 
is susceptible to high levels of ROS associated with normal cellular physiology and acute and chronic injury (Novo and M, 
2008), we sought to compare Prdx1 and Prdx6 induction by serum and phorbol ester in H2.35 cells. Given that these 
proteins represent two distinct members of the peroxiredoxin family expressed in liver, understanding their regulation in 
hepatocytes can provide important insight into their relative roles in the cellular response to stress in this tissue.  
2. Materials & Methods 
2.1 Cells, Inducers & Inhibitors
The H2.35 hepatocyte cell line (ATCC) was cultured in DMEM with 4% FCS and 0.2PM dexamethasone, and grown at 
33qC in a 10% CO2 atmosphere. Phorbol-12-myristate-13-acetate (TPA) (Cell Signaling Technologies) was supplied as a 
200 PM stock in DMSO. Mitrhamycin A (Tocris) was dissolved in DMSO to 10 mM, and subsequently diluted to 10 PM
in PBS. 
2.2 Real-Time PCR 
For real-time PCR studies, H2.35 cells were plated into 96-well plates at a cell density of approximately 20%, and 
cultured under appropriate experimental conditions. At the time of harvest, media was removed and adherent cells were 
rinsed with cold 1X PBS. Cell lysates and reverse transcriptase reactions were performed using the Cells-to-CT Kit 
(Applied Biosystems). Briefly, cells were lysed in Cell Lysis solution containing DNAseI for five minutes, followed by 
two-minute incubation with the stop solution. Cell lysates were immediately used for RT reactions, or were stored 
temporarily at -20 degrees, to be used within 2 weeks. Fifty-microliter reverse transcription reactions were performed 
using 10 Pl of each cell lysate, according to the manufacturer’s suggestions. Twenty-Pl PCR reactions were performed 
in triplicate for each target gene using 2 Pl RT reaction, 7 Pl water, 10 Pl of 2X Taqman PCR buffer (Cells-to-CT kit), 
and 1 Pl of the appropriate mouse TaqMan assay: Prdx1 (Mm01621996_s1), Prdx6 (Mm00725435_s1), beta-actin 
endogenous control (4352933E), or 18s control (4333760F). To ensure that PCR amplification was not due to genomic 
DNA contamination, parallel RT-reactions were performed in the absence of reverse transcriptase for each experiment. 
In all cases, reactions from RTs lacking reverse transcriptase amplified no product, or resulted in cycle threshold (Ct) 
values beyond 35 and seven CTs higher than the positive reactions, representing negligible genomic DNA 
contamination. Relative expression was calculated using the CT method (Livak and Schmittgen, 2001), with each target 
gene normalized against beta-actin levels for the same sample. An appropriate calibrator was chosen for each analysis, 
and all other samples were calibrated against that sample. All treatments were done in triplicate wells, and experiments 
were repeated. 
2.3 Western Blotting 
H2.35 cells were cultured in 60 mm dishes to near confluence under appropriate experimental conditions. Media was 
discarded, and cells were washed with 2 mL of cold 1X PBS. Cells were lysed in 100 Pl of M-PER reagent (Thermo 
Scientific) at room temperature rocking for 10 minutes, and lysates were collected, spun to remove cell debris, and 
supernatants transferred to tubes. Total protein was quantified using the Biorad Protein Assay (Biorad) according to 
manufacturer’s recommendations. Twenty-five Pg of protein from each sample were separated on 10% tris-HCL gel 
(Biorad) under denaturing conditions and transferred to PVDF membranes. Membranes were blocked for 15 minutes in 
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4% skim milk in TBST, and incubated overnight at 4qC with 1:1,000 dilution of Prdx6 antibody (Biosensis, R-169-100) 
and 1:5,000 dilution of beta-actin antibody (Sigma, A5441) diluted in 1% dry milk in TBST. Blots were rinsed 3 x15 
minutes in TBST and incubated for one hour at room temperature with alkaline phosphatase-linked secondary 
antibodies (Sigma) diluted in 1% dry milk in TBST. Blots were again rinsed 3 x 15 minutes in TBST, followed by 5 
minutes in TBS, and then BCIP/NBT substrate was added until band appearance. Reactions were stopped with distilled 
water.
2.4 Synthesis of Deletion Constructs & Transfections 
Various deletions of the Prdx6 mouse promoter had previously been cloned into the pSEAP2-Basic vector (Clontech) 
by our laboratory, as previously described (Gallagher and Phelan, 2007). These included constructs containing the 
mouse Prdx6 promoter fragment that extends to nucleotide position -184 (relative to the +1 transcription start site). 
Primers used to amplify the -184 fragment were: Prom-184 forward 
(5’-CGCTCGAGTACAAGTCCCCGCAATTCTC-3’) and PromReverse (5’- CGAAGCTTGTGGTGACGC 
TGAGAACAAGG-3’). The PCR products were amplified and cloned into the pSEAP2-Basic reporter vector (Clontech) 
as previously described. H2.35 cells were seeded into 48-well cell culture plates and grown overnight. For each 
transfection, 0.4 Pg of the -184-SEAP2 construct and 0.1 Pg of the pGluc-control plasmid were mixed with 
lipofectamine 2000 reagent (Invitrogen) according to manufacturer’s suggestions. Cell media in each well was replaced 
with either normal growth media or serum free/dexamethasone free media and transfection mixes were added. For 
Sp1-inhibition studies, mithramycin A was added two hours after transfection. Transfected cells were incubated under 
normal growth conditions for five days and media collected and spun to remove debris. 
2.5 Reporter Assays 
The QUANTI-Blue Reagent (Invivogen) was used to measure SEAP levels in cell supernatants. The reagent was freshly 
prepared from the supplied powder by dissolving one packet in 100 ml sterile water, and filtering through a 0.2 Pm
membrane. For each assay, 20 Pl of sample media were added to 200 Pl of QUANTI-Blue reagent, and incubated at 37qC
for 24 hours. The absorbance at 655 nM was measured for each sample, and blanked against reagent plus 20 Pl
appropriate media. For luciferase expression, the Gaussia Luciferase Assay was used (New England Biolabs). Briefly, 15 
Pl of each media sample was added to a separate well of a 96 well flat bottom white plate. Using the Tecan Infinite F200 
microplate reader (Tecan), 50 Pl of reconstituted luciferase substrate was auto-injected into each well, mixed for 2 
seconds, and integrated for 5 seconds to measure luminescence. All SEAP levels were normalized against relative 
luciferase levels. 
2.6 Sequence Analysis 
The proximal 184 nucleotides of the mouse Prdx6 promoter were analyzed for putative transcription factor binding sites 
using TFSEARCH version 1.3 (Heinemeyer et al., 1998).
3. Results 
3.1 Induction of Prdx1 and Prdx6 mRNA by Serum and TPA 
We previously determined that Prdx6 expression is significantly inhibited in H2.35 cells upon serum deprivation 
(Gallagher and Phelan, 2007). To quantify this effect and compare this response to that of Prdx1, we examined the 
expression of both genes in the presence and absence of serum. As shown in Figure 1A, Prdx1 expression is moderately, 
but significantly, increased (by approximately 30%) in complete growth media as compared to serum-deprived conditions 
(p<0.05). In contrast, Prdx6 expression is elevated three-fold in the presence of serum (p<0.001). These data indicate that 
Prdx6 is more highly elevated in proliferating vs. quiescent cells as compared to Prdx1. Since Prdx1 is regulated by TPA 
in other cells (Hess et al., 2003), we also examined the regulation of Prdx1 and Prdx6 by TPA in H2.35 cells. As shown in 
Figure 1B, TPA also induced the expression of both genes, but with a much greater effect on Prdx6. Prdx1 was 
upregulated by TPA by approximately 30% after 8 hours (p<0.005). After 8 hours of TPA treatment, Prdx6 was induced 
approximately two-fold (p<0.005). These data suggest that both genes may be involved in the cellular response to these 
stimuli, but possibly to different degrees. 
3.2 Induction of Prdx1 and Prdx6 Protein by Serum and TPA 
To determine if the significant increase in Prdx6 mRNA in response to serum and TPA resulted in a corresponding protein 
induction, we used western blotting to measure Prdx6 protein levels before and after stimulation. As shown in Figure 2A, 
the addition of serum to serum-deprived H2.35 cells for eight hours led to an increase in Prdx6 protein expression. 
Likewise, eight hours of TPA stimulation also resulted in an increase in Prdx6 protein levels. This data suggests that 
serum and TPA result in a marked increase in the amount of Prdx6 protein in H2.35 liver cells. 
3.3 Identification of Sp1 Sites in Prdx6 Promoter 
Based on the marked upregulation of Prdx6 in growing cells and in response to TPA, we were interested in identifying 
potential transcriptional regulators of Prdx6 that may mediate its induction by one or both of these stimuli. We previously 
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synthesized several deletion constructs of the mouse Prdx6 promoter, linked to the pSEAP2-basic reporter gene 
(Gallagher and Phelan, 2007). We analyzed the smallest of these fragments, containing the proximal 184 nucleotides of 
the mouse Prdx6 promoter, for consensus transcription factor binding sites against the TransFac4.0 database (Heinemeyer 
et al., 1998). We found three putative Sp1 sites in this sequence, shown in Figure 3 (with the location of the consensus Sp1 
sites indicated). In addition, we identified consensus E-box sequences which are putative binding sites for Upstream 
Stimulatory Factor (USF) and Myc. 
3.4 Effect of Mithramycin A on Prdx6 Induction 
To test whether Sp1 is involved in the regulation of Prdx6 in growing H2.35 cells, we compared SEAP reporter expression 
from the SEAP-184 construct in the presence and absence of Mithramycin A, a potent Sp1 inhibitor. As shown in Figure 
4A, SEAP expression driven by this proximal promoter is almost completely inhibited by Mithramycin A (p<0.05). There 
is no significant difference between serum-stimulated reporter expression in the presence of mithramycin A and levels 
found in the absence of serum, suggesting that Sp1 sites in the proximal promoter are largely responsible for the 
transcriptional activity of this region in growing cells. We also wanted to test whether Sp1 is also involved in the 
induction of Prdx6 in response to TPA. Experiments using TPA induction of the SEAP-184 construct resulted in no 
induction (data not shown) suggesting that this proximal promoter is not sufficient to drive induction by TPA. Therefore, 
we measured Prdx6 expression by real time PCR in serum-deprived cells treated with and without mithramycin A. As 
shown in Figure 4B, Mithramycin A treatment partially inhibited the TPA-stimulated induction of Prdx6 (p<0.05). 
Although the level of Prdx6 expression in the presence of mithramycin A was significantly suppressed, it was not as low 
as serum-deprived levels (data not shown).  
4. Discussion 
4.1 Summary 
The mammalian peroxiredoxin family of proteins includes structurally and functionally distinct members that protect 
different cell types from oxidative stress-induced damage. However, the precise role for these proteins in different cells, 
and the mechanism by which they are transcriptionally regulated in response to oxidative insult, remains unclear. In the 
present study, we compared the regulation of Prdx1 and Prdx6 in the H2.35 cell line using real time PCR. We showed that 
both genes are induced at the mRNA level in response to serum and TPA, with a much more robust effect on Prdx6. Prdx6 
induction translated into a corresponding increase in Prdx6 protein expression. We further showed that treatment with 
mithramycin A resulted in a partial block of TPA-stimulated induction of Prdx6. Examination of the proximal Prdx6 
promoter containing four Sp1 sites further showed complete inhibition of serum-stimulated promoter activity upon 
mithramycin A treatment. Together, these data suggest that Prdx6 is particularly responsive to serum and TPA stimulation 
in H2.35 cells, and implicate Sp1 as a possible mediator of Prdx6 induction.  
4.2 Regulation of Peroxiredoxins by Serum 
The cellular regulation of peroxiredoxin activity is known to occur at many levels, suggesting that tight control of this 
family is critical (Rhee et al., 2005). A wide variety of oxidative stress-inducing agents, including growth factors and 
cytokines, stimulate peroxiredoxin expression at the level of gene expression. Prdx1 mRNA is upregulated by hypoxia, 
H202, and tert-BOOH (Prosperi et al., 1998; Li et al., 2002; Rhee et al., 2005; Kim et al., 2007), as well as serum (Prosperi 
et al., 1998). Likewise, Prdx6 expression is induced by hyperoxia, H202, and nitric oxide (Kim et al., 2002; Kim et al., 
2003; Sparling and Phelan, 2003; Simeone and Phelan, 2005; Chowdhury et al., 2007; Diet et al., 2007; Gallagher and 
Phelan, 2007; Chowdhury et al., 2009), and also by growth stimuli including keratinocyte growth factor (KGF) (Frank 
and Werner, 1997; Munz et al., 1997; Sparling and Phelan, 2003; Gallagher and Phelan, 2007), lens epithelium-derived 
growth factor (LEDGF) (Fatma et al., 2001), and TNF-D (Kubo et al., 2006; Gallagher and Phelan, 2007). One of the most 
significant differences we observed between Prdx1 and Prdx6 in the present study is their expression in growing vs. 
quiescent cells. The observation that Prdx6 is three times higher in growing H2.35 cells vs. serum deprived cells suggests 
an important role for Prdx6 in this growth response. We previously reported the upregulation of Prdx6 in H2.35 cells by 
serum (Sparling and Phelan, 2003; Simeone and Phelan, 2005; Gallagher and Phelan, 2007), and others have 
demonstrated increased Prdx6 in hyperproliferative epithelium of wounded and psoriatic skin (Kumin et al., 2006). In 
addition, Prdx6 levels seem to be inversely correlated with TGF-E levels in the lens (Kubo et al., 2006). Together, these 
data implicate Prdx6 in the maintenance of cellular homeostasis in proliferating cells.  
4.3 Regulation of Peroxiredoxins by TPA 
TPA is both a known tumor promoter and inducer of apoptosis in various cell types. Although the mechanism by which it 
elicits these two effects is unclear, the requirement of ROS in TPA-induced toxicity has been demonstrated (Lin et al., 
2006). Induction of Prdx1 by TPA in H2.35 cells is not surprising given a prior study reporting Prdx1 induction by TPA in 
rat liver tissue macrophages and monocytic cells through a PKC/Ras/p38MAPK pathway (Hess et al., 2003). While this 
study reported nearly eight-fold induction by six hours, our results suggest a more modest effect on Prdx1 in H2.35 cells. 
The more dramatic induction of Prdx6 by TPA may represent the relative importance of these proteins in these cells, or 
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may simply suggest a more critical role for Prdx6 in the TPA response, as prior studies have not examined induction of 
Prdx6 by TPA in any cell line.  
4.4 Potential Role of Sp1 in Prdx6 Regulation by Serum 
Previous studies from our lab identified the proximal -184 bp of the mouse Prdx6 promoter as sufficient to drive reporter 
expression in growing H2.35 cells. Our present observations that mithramycin A inhibits this induction to a level 
comparable to that observed in serum-derived cells implicates Sp1 as a possible regulator of this activity. Sp1 is a 
redox-regulated transcription factor that has been implicated in the control of cell-cycle genes in normal cell proliferation 
and cancer (Safe and Abdelrahim, 2005). A prior study demonstrated that the middle Sp1 site bound to Sp1 in gel shift 
assays (Lee et al., 1999), although the other sites were not examined and corresponding transcriptional activity was never 
reported. Given its known role in proliferation, it is possible that Sp1 activity is upregulated in growing H2.35 cells and 
induces Prdx6 as a mechanism of balancing the increased cellular ROS. Since mithramycin A binds to many G-C rich 
DNA sequences, it is also possible that one or more other DNA binding proteins are responsible for, or contribute to, the 
serum-stimulated Prdx6 promoter activity seen in H2.35 cells. In addition to the Sp1 sites, the proximal promoter includes 
two consensus E-box sequences for Upstream Stimulatory Factor (USF) and Myc (shown in Figure 3). Interestingly, 
Prdx1 binds to the myc protein and suppresses its function (Mu et al., 2002), and a recent study found a myc-dependent 
regulation of Prdx5 by Prdx1 (Graves et al., 2009), demonstrating myc as a peroxiredoxin regulator. Mithramycin A is 
also known to suppress myc DNA binding activity, so the inhibitory effect of mithramycin A on Prdx6 induction by serum 
and TPA may be attributed to suppression of myc, rather than Sp1. This will require further investigation.  
4.5 Other Possible Mechanisms of Prdx6 Regulation 
The inhibitory effect of Mithramycin A on Prdx6 stimulation by TPA suggests that Sp1 may be involved in mediating part 
of this response. TPA has been shown to increase transcription of another antioxidant gene, manganese superoxide 
dismutase, through activation of Sp1 (Porntadavity et al., 2001). Despite a possible role for Sp1 in this activation, the 
inability of the proximal promoter to respond to TPA suggests that Prdx6 upregulation by TPA likely requires additional 
upstream regulatory elements and other transcription factors. A recent study revealed that the human Prdx6 gene is 
transcriptionally regulated through an antioxidant response element (Chowdhury et al., 2009), although a similar element 
is not found in the mouse promoter. In addition to the previously mentioned consensus sequences, two putative AP1 sites 
are found between 340 and 470 nucleotides upstream of the transcription start site. It is worth noting that the 
TPA-dependent induction of Prdx1 reported by Hess et al. was mediated by two proximal AP-1 sites targeted by c-Jun 
(Hess et al., 2003). The investigation of these potential regulatory elements and the corresponding DNA binding proteins 
will provide greater insight into the transcriptional regulation of Prdx6. Together with additional functional analyses these 
studies will help to reveal the precise role for this protein in liver cell physiology and stress responses. 
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Figure 1. Induction of Prdx1 and Prdx6 by Serum and TPA 
H2.35 cells were cultured in complete growth media or serum-free/dexamethasone-free media for 24 hours (A) and 
serum-free/dexamethasone-free treated cells were subsequently treated with or without 0.5 PM TPA for an additional 
eight hours (B). All cells were lysed, RT-reactions were performed, and Prdx1, Prdx6, and beta-actin mRNA levels were 
quantified by Real-Time PCR as described in Materials & Methods. Relative expression was calculated using the CT
method, normalizing to actin and calibrating against the serum-deprived expression level for each gene. Averages of three 
independent replicates are shown (+/- SDM). 




Figure 2. Prdx6 Protein Induction by Serum and TPA 
(A) Western blot of Prdx6 and beta-actin in H2.35 cells under serum deprived and growing conditions. (B) Western 
blot of Prdx6 and beta-actin in serum deprived H2.35 cells in the absence or presence of 0.5 PM TPA for eight 
hours.  
Figure 3. Prdx6 Proximal Promoter Sequence 
Nucleotide sequence of the proximal 184 nucleotides of the mouse Prdx6 promoter. Nucleotide number is relative to the 
transcription start site for the gene. This sequence corresponds to the region used in the SEAP reporter analysis. 




Figure 4. Effect of Mithramycin A on Prdx6 Regulation. 
(A) H2.35 cells were transfected with pGluc control vector and SEAP2-184 reporter construct in the indicated media. 
Two hours after transfection, cells were treated with or without 100 nM mithramycin A, and subsequently cultured 
under the indicated conditions for five days. SEAP and luciferase activity were measured as described in Materials and 
Methods. Averages of normalized SEAP reporter expression for three independent replicates are shown (+/- SDM). (B) 
H2.35 cells were cultured in serum-free/dexamethasone-free media and treated with 0.5 PM TPA for eight hours in the 
presence or absence of 100 nM mithramycin A. All cells were lysed, RT-reactions were performed, and Prdx1, Prdx6,
and 18S mRNA levels were quantified by Real-Time PCR as described in Materials & Methods. Relative expression 
was calculated using the CT method, normalizing to 18s. Averages of three independent replicates are shown (+/- SDM).
